MolecuLight Inc. exhibited at the 2016 SAWC Spring Conference that took place on April 13-17 at the Georgia World Congress Center in Atlanta, GA, USA.
There were over 150 Exhibitors from around the World.
Dr. Stephan Landis MD, FRCP(C) gave an oral poster presentation on Determining the Effectiveness of Sharp Debridement Using Wound/Periwound Bacterial Autofluorescence Imaging.
We look forward to next year’s conference.
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.